Doesn't look like the market was overly impressed with this data even at these levels (share price of 15 cents) ..... I guess the small trial size of 15 participants and the fact that is was a phase 1 trial didn't help either ?
Agree @Pledge it's certainly taking a long while to get this CYP phase 2 GVHD trial started ... IMHO they are wanting to know if their competitor's FDA approval for GVHD goes through before they start but then again they have stopped other trials before due to an inability to recruit participants, so there is that ?
Ann: Two-Year Results of Phase 1 SR-aGvHD Trial Presented at ISCT, page-11
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
15.5¢ |
Change
-0.005(3.13%) |
Mkt cap ! $35.02M | |||
| Open | High | Low | Value | Volume |
| 16.0¢ | 16.5¢ | 15.5¢ | $22.43K | 139.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 58708 | 15.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 16.0¢ | 9763 | 1 |
View Market Depth
| Last trade - 16.10pm 26/06/2025 (20 minute delay) ? |
| CYP (ASX) Chart |